IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies
AL Hardaway, I Podgorski - Future Medicinal Chemistry, 2013 - Future Science
Within the past decade, inflammatory and lipid mediators, such as IL-1β, FABP4 and RAGE,
have emerged as important contributors to metabolic dysfunction. As growing experimental …
have emerged as important contributors to metabolic dysfunction. As growing experimental …
[PDF][PDF] IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies
AL Hardaway, I Podgorski - Future, 2013 - researchgate.net
Within the past decade, inflammatory and lipid mediators, such as IL-1β, FABP4 and RAGE,
have emerged as important contributors to metabolic dysfunction. As growing experimental …
have emerged as important contributors to metabolic dysfunction. As growing experimental …
IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies
AL Hardaway, I Podgorski - Future medicinal chemistry, 2013 - pubmed.ncbi.nlm.nih.gov
Within the past decade, inflammatory and lipid mediators, such as IL-1β, FABP4 and RAGE,
have emerged as important contributors to metabolic dysfunction. As growing experimental …
have emerged as important contributors to metabolic dysfunction. As growing experimental …
Il-1β, Rage and Fabp4: Targeting the Dynamic Trio in Metabolic Inflammation and Related Pathologies
AL Hardaway, I Podgorski - Future Medicinal Chemistry, 2013 - Taylor & Francis
Within the past decade, inflammatory and lipid mediators, such as IL-1β, FABP4 and RAGE,
have emerged as important contributors to metabolic dysfunction. As growing experimental …
have emerged as important contributors to metabolic dysfunction. As growing experimental …
[HTML][HTML] IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies
AL Hardaway, I Podgorski - Future medicinal chemistry, 2013 - ncbi.nlm.nih.gov
Within the past decade, inflammatory and lipid mediators, such as IL-1β, FABP4 and RAGE,
have emerged as important contributors to metabolic dysfunction. As growing experimental …
have emerged as important contributors to metabolic dysfunction. As growing experimental …
IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies
AL Hardaway, I Podgorski - Future Medicinal Chemistry, 2013 - cir.nii.ac.jp
抄録< jats: p> Within the past decade, inflammatory and lipid mediators, such as IL-1β,
FABP4 and RAGE, have emerged as important contributors to metabolic dysfunction. As …
FABP4 and RAGE, have emerged as important contributors to metabolic dysfunction. As …
IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.
AL Hardaway, I Podgorski - Future Medicinal Chemistry, 2013 - europepmc.org
Within the past decade, inflammatory and lipid mediators, such as IL-1β, FABP4 and RAGE,
have emerged as important contributors to metabolic dysfunction. As growing experimental …
have emerged as important contributors to metabolic dysfunction. As growing experimental …
IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.
AL Hardaway, I Podgorski - Future Medicinal Chemistry, 2013 - europepmc.org
Within the past decade, inflammatory and lipid mediators, such as IL-1β, FABP4 and RAGE,
have emerged as important contributors to metabolic dysfunction. As growing experimental …
have emerged as important contributors to metabolic dysfunction. As growing experimental …
[PDF][PDF] IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies
AL Hardaway, I Podgorski - Future, 2013 - researchgate.net
Within the past decade, inflammatory and lipid mediators, such as IL-1β, FABP4 and RAGE,
have emerged as important contributors to metabolic dysfunction. As growing experimental …
have emerged as important contributors to metabolic dysfunction. As growing experimental …